SCHEMBL25413293

SCHEMBL25413293

O=C(c1ccccc1)c1cc(Cl)ccc1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.57
ALDH1A1 P00352 4/20 0.56
MAPK1 P28482 2/20 0.54
GAA P10253 1/20 0.51
CYP19A1 P11511 1/20 0.51
TSHR P16473 1/20 0.50
MITF O75030 1/20 0.50
HSP90AA1 P07900 1/20 0.50
HTT P42858 1/20 0.50
ATM Q13315 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TLR9 Q9NR96 1/20 0.50
POLB P06746 1/20 0.49
BCL2L1 Q07817 1/20 0.49
MAPT P10636 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
HPGD P15428 1/20 0.49
CYP2C19 P33261 1/20 0.49
CES2 O00748 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31366649 1.00 VCAM1 (0.57) VCAM1ALDH1A1MAPK1GAACYP19A1
Methylamine SCHEMBL27483022 0.96 MAPK1 (0.54) VCAM1ALDH1A1MAPK1GAACYP19A1
SCHEMBL10396627 0.90 ALDH1A1 (0.58) VCAM1ALDH1A1MAPK1GAATSHR
SCHEMBL11289155 0.88 HPGD (0.59) VCAM1ALDH1A1MAPK1POLBBCL2L1
SCHEMBL27631145 0.85 VCAM1 (0.49) VCAM1ALDH1A1MAPK1GAAMITF
SCHEMBL21202543 0.84 ALDH1A1 (0.52) VCAM1ALDH1A1MAPK1GAACYP19A1
SCHEMBL343417 0.84 ALDH1A1 (0.52) VCAM1ALDH1A1MAPK1GAATSHR
SCHEMBL13240120 0.83 RECQL (0.65) VCAM1ALDH1A1MAPK1GAATSHR
SCHEMBL28081755 0.83 ALDH1A1 (0.57) VCAM1ALDH1A1MAPK1GAACYP19A1
SCHEMBL11294315 0.82 VCAM1 (0.55) VCAM1ALDH1A1MAPK1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250197360-A1 NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE BARUCH S. BLUMBERG INSTITUTE 2025-06-19 US disclosed
WO-2023172726-A1 NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE BARUCH S. BLUMBERG INSTITUTE (US) 2023-09-14 WO disclosed
CN-106413710-A Factor xia inhibitors 默沙东公司 2017-02-15 CN disclosed
CN-103717588-B Pyrazole derivatives 绿色科技株式会社 2016-08-03 CN disclosed
CN-101141880-A Herbicidal compositions based on 3-phenyluracil and 3-sulfonylisoxazole 58743 BASF AG (DE) 2008-03-12 CN disclosed
CN-1191049-C Cationic monophenyl-nitro-diamino compounds and use in dyeing cutin fiber, dyeing composition containing said matter OREAL (FR) 2005-03-02 CN disclosed
CN-1261529-A Cationic monophenyl-nitro-diamino compounds and use in dyeing cutin fiber, dyeing composition containing said matter OREAL (FR) 2000-08-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197360-A1 NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE CUL4B, BRD4, CUL4A VCAM1 1718/4885ALDH1A1 4616/4885MAPK1 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.